Estrogen and Progesterone Replacement Therapy Prevent Methamphetamine-Induced Synaptic Plasticity Impairment in Ovariectomized Rats

Document Type : Original Article(s)

Authors

1 PhD Candidate, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

2 Associate Professor, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

3 Assistant Professor, Cognitive and Neuroscience Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

4 Professor, Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Background: Methamphetamine (METH) is one of the most popular psychostimulants which produce long lasting learning and memory impairment. Previous studies have indicated that estrogen and progesterone replacement therapy attenuate cognitive impairment against a wide array of neurodegenerative diseases. Present study was designed to figure out the effects of estrogen, progesterone alone or in combination, on early long-term potentiation (E-LTP) at the cornu ammonis (CA1) area of the hippocampus in METH-exposed ovariectomized (OVX) rat.Methods: Twenty-one days after ovariectomy, the OVX rats received vehicle, estrogen [1 mg/kg, intraperitoneal (IP)] or progesterone (8 mg/kg, IP) and co-administration of estrogen plus progesterone during 14 consecutive days. On the 28th day, animals were exposed to neurotoxic METH regimens [four injections 6 mg/kg, subcutaneous (SC), 2 h intervals] 30 min after the hormones replacement. Finally, we investigated the effect of those ovarian hormones on synaptic plasticity using in vivo extracellular recording in the CA1 area of the hippocampus 2 days after last treatment.Findings: The findings showed that the induction and maintenance phase of E-LTP was impaired in the METH exposed animals compared to the saline group. Data from this study demonstrated that treatment with estrogen and progesterone showed a significant facilitation for induction and enhancement of the maintenance of LTP in animals that received METH. In addition, co-administration of estrogen plus progesterone did not significantly affect the hippocampal synaptic plasticity in METH-exposed OVX rats in comparison with METH-exposed animals that received vehicle injections.Conclusion: The present findings provide new insight about treatment with ovarian hormones on synaptic plasticity deficits induced by METH.

Keywords


  1. Amiri S, Alijanpour S, Tirgar F, Haj-Mirzaian A, Amini-Khoei H, Rahimi-Balaei M, et al. NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice. Neuroscience 2016; 329: 122-33.
  2. Tirgar F, Rezayof A, Zarrindast MR. Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia. Neuroscience 2014; 277: 392-402.
  3. Kalant OJ. The amphetamines; toxicity and addiction. Toronto, ON: University of Toronto Press; 1973.
  4. Acute public health consequences of methamphetamine laboratories--16 states, January 2000-June 2004. MMWR Morb Mortal Wkly Rep 2005; 54(14): 356-9.
  5. Camarasa J, Rodrigo T, Pubill D, Escubedo E. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats. Pharmacol Res 2010; 62(5): 450-6.
  6. Nagai T, Takuma K, Dohniwa M, Ibi D, Mizoguchi H, Kamei H, et al. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 2007; 194(1): 21-32.
  7. Hori N, Kadota MT, Watanabe M, Ito Y, Akaike N, Carpenter DO. Neurotoxic effects of methamphetamine on rat hippocampus pyramidal neurons. Cell Mol Neurobiol 2010; 30(6): 849-56.
  8. Williams MT, Brown RW, Vorhees CV. Neonatal methamphetamine administration induces
  9. region-specific long-term neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur J Neurosci 2004; 19(12): 3165-70.
  10. Swant J, Chirwa S, Stanwood G, Khoshbouei H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 2010; 5(6): e11382.
  11. Sheibani V, Afarinesh M, Hajializadeh Z, Abbasnejad M, Haghpanah T, Arabnezhad R, et al. Evaluation of Origanum Vulgare L. ssp. viridis leaves extract effect on discrimination learning and ltp induction in the ca1 region of the rat hippocampus. Iran J Basic Med Sci 2011; 14(1): 177-84.
  12. Haghpanah T, Esmailpour Bezanjani K, Afarinesh Khaki MR, Sheibani V, Abbasnejad M, Masoomi Ardakani Y. Effect of intra-hippocampal injection of Origanum vulgare L. ssp. viridis leaf extract on Spatial learning and memory consolidation. Feyz 2011; 14(4): 380-7. [In Persian].
  13. Frye CA, Walf AA. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behav Neurosci 2004; 118(2): 306-13.
  14. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000; 21(1): 107-16.
  15. Chesler EJ, Juraska JM. Acute administration of estrogen and progesterone impairs the acquisition of the spatial morris water maze in ovariectomized rats. Horm Behav 2000; 38: 234-42.
  16. Dai X, Chen L, Sokabe M. Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neurons. Neuropharmacology 2007; 52(4): 1124-38.
  17. Plamondon H, Morin A, Charron C. Chronic 17beta-estradiol pretreatment and ischemia-induced hippocampal degeneration and memory impairments: a 6-month survival study. Horm Behav 2006; 50(3): 361-9.
  18. Morali G, Letechipia-Vallejo G, Lopez-Loeza E, Montes P, Hernandez-Morales L, Cervantes M. Post-ischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus. Neurosci Lett 2005; 382(3): 286-90.
  19. Nezhadi A, Sheibani V, Esmaeilpour K, Shabani M, Esmaeili-Mahani S. Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson's disease. Behav Brain Res 2016; 305: 258-64.
  20. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 1997; 48(5 Suppl 7): S8-15.
  21. Murphy DD, Cole NB, Greenberger V, Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 1998; 18(7): 2550-9.
  22. Warren SG, Humphreys AG, Juraska JM, Greenough WT. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res 1995; 703(1-2): 26-30.
  23. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003; 289(20): 2651-62.
  24. Gajjar TM, Anderson LI, Dluzen DE. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm (Vienna) 2003; 110(11): 1215-24.
  25. Yu L, Liao PC. Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. J Neural Transm (Vienna) 2000; 107(10): 1139-47.
  26. Ghazvini H, Khaksari M, Esmaeilpour K, Shabani M, Asadi-Shekaari M, Khodamoradi M, et al. Effects of treatment with estrogen and progesterone on the methamphetamine-induced cognitive impairment in ovariectomized rats. Neurosci Lett 2016; 619: 60-7.
  27. Khaksari M, Soltani Z, Shahrokhi N, Moshtaghi G, Asadikaram G. The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury. Can J Physiol Pharmacol 2011; 89(1): 31-40.
  28. Hajali V, Sheibani V, Ghazvini H, Ghadiri T, Valizadeh T, Saadati H, et al. Effect of castration on the susceptibility of male rats to the sleep deprivation-induced impairment of behavioral and synaptic plasticity. Neurobiol Learn Mem 2015; 123: 140-8.
  29. Saadati H, Sheibani V, Esmaeili-Mahani S, Hajali V, Mazhari S. Prior regular exercise prevents synaptic plasticity impairment in sleep deprived female rats. Brain Res Bull 2014; 108: 100-5.
  30. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Philadelphia, PA: Elsevier; 2007.
  31. Khodamoradi M, Asadi-Shekaari M, Esmaeili-Mahani S, Esmaeilpour K, Sheibani V. Effects of genistein on cognitive dysfunction and hippocampal synaptic plasticity impairment in an ovariectomized rat kainic acid model of seizure. Eur J Pharmacol 2016; 786: 1-9.
  32. Geinisman Y. Structural synaptic modifications associated with hippocampal LTP and behavioral learning. Cereb Cortex 2000; 10(10): 952-62.
  33. Oomura Y, Hori N, Shiraishi T, Fukunaga K, Takeda H, Tsuji M, et al. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006; 27(11): 2738-49.
  34. Reichel CM, Ramsey LA, Schwendt M, McGinty JF, See RE. Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 2012; 62(2): 1119-26.
  35. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008; 62(2): 91-100.
  36. Schmued LC, Bowyer JF. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res 1997; 759(1): 135-40.
  37. Dawirs RR, Teuchert-Noodt G, Busse M. Single doses of methamphetamine cause changes in the density of dendritic spines in the prefrontal cortex of gerbils (Meriones unguiculatus). Neuropharmacology 1991; 30(3): 275-82.
  38. Sharma HS, Kiyatkin EA. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: An experimental study using light and electron microscopy. J Chem Neuroanat 2009; 37(1): 18-32.
  39. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24(26): 6028-36.
  40. Granado N, Lastres-Becker I, Ares-Santos S, Oliva I, Martin E, Cuadrado A, et al. Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Glia 2011; 59(12): 1850-63.
  41. Li XH, Li CY, Lu JM, Tian RB, Wei J. Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Neurosci Lett 2012; 514(1): 46-50.
  42. Khalifeh S, Oryan S, Digaleh H, Shaerzadeh F, Khodagholi F, Maghsoudi N, et al. Involvement of Nrf2 in development of anxiety-like behavior by linking Bcl2 to oxidative phosphorylation: Estimation in rat hippocampus, amygdala, and prefrontal cortex. J Mol Neurosci 2015; 55(2): 492-9.
  43. Khalifeh S, Oryan S, Khodagholi F, Digaleh H, Shaerzadeh F, Maghsoudi N, et al. Complexity of compensatory effects in nrf1 knockdown: Linking undeveloped anxiety-like behavior to prevented mitochondrial dysfunction and oxidative stress. Cell Mol Neurobiol 2016; 36(4): 553-63.
  44. Goss CW, Hoffman SW, Stein DG. Behavioral effects and anatomic correlates after brain injury: A progesterone dose-response study. Pharmacol Biochem Behav 2003; 76(2): 231-42.
  45. Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996; 87(7): 1327-38.
  46. Malenka RC, Bear MF. LTP and LTD: An embarrassment of riches. Neuron 2004; 44(1): 5-21.
  47. Leuner B, Shors TJ. New spines, new memories. Mol Neurobiol 2004; 29(2): 117-30.
  48. McEwen B, Akama K, Alves S, Brake WG, Bulloch K, Lee S, et al. Tracking the estrogen receptor in neurons: Implications for estrogen-induced synapse formation. Proc Natl Acad Sci U S A 2001; 98(13): 7093-100.
  49. Zhao Y, Wang J, Liu C, Jiang C, Zhao C, Zhu Z. Progesterone influences postischemic synaptogenesis in the CA1 region of the hippocampus in rats. Synapse 2011; 65(9): 880-91.
  50. Warren MW, Kobeissy FH, Liu MC, Hayes RL, Gold MS, Wang KK. Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injury. Life Sci 2005; 78(3): 301-9.
  51. Gold MS, Kobeissy FH, Wang KK, Merlo LJ, Bruijnzeel AW, Krasnova IN, et al. Methamphetamine- and trauma-induced brain injuries: Comparative cellular and molecular neurobiological substrates. Biol Psychiatry 2009; 66(2): 118-27.
  52. Harburger LL, Bennett JC, Frick KM. Effects of estrogen and progesterone on spatial memory consolidation in aged females. Neurobiol Aging 2007; 28(4): 602-10.
  53. Mannella P, Sanchez AM, Giretti MS, Genazzani AR, Simoncini T. Oestrogen and progestins differently prevent glutamate toxicity in cortical neurons depending on prior hormonal exposure via the induction of neural nitric oxide synthase. Steroids 2009; 74(8): 650-6.
  54. Baudry M, Bi X, Aguirre C. Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience 2013; 239: 280-94.
  55. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990; 10(4): 1286-91.
  56. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992; 12(7): 2549-54.
  57. Murphy DD, Segal M. Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology 2000; 72(3): 133-43.
  58. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm AC. Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci 2006; 24(1): 229-42.